BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26718126)

  • 1. General Purpose 2D and 3D Similarity Approach to Identify hERG Blockers.
    Schyman P; Liu R; Wallqvist A
    J Chem Inf Model; 2016 Jan; 56(1):213-22. PubMed ID: 26718126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets.
    Shen MY; Su BH; Esposito EX; Hopfinger AJ; Tseng YJ
    Chem Res Toxicol; 2011 Jun; 24(6):934-49. PubMed ID: 21504223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined receptor and ligand-based approach to the universal pharmacophore model development for studies of drug blockade to the hERG1 pore domain.
    Durdagi S; Duff HJ; Noskov SY
    J Chem Inf Model; 2011 Feb; 51(2):463-74. PubMed ID: 21241063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarity-based SIBAR descriptors for classification of chemically diverse hERG blockers.
    Thai KM; Ecker GF
    Mol Divers; 2009 Aug; 13(3):321-36. PubMed ID: 19219559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico prediction of hERG inhibition.
    Jing Y; Easter A; Peters D; Kim N; Enyedy IJ
    Future Med Chem; 2015; 7(5):571-86. PubMed ID: 25921399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico prediction of the chemical block of human ether-a-go-go-related gene (hERG) K+ current.
    Inanobe A; Kamiya N; Murakami S; Fukunishi Y; Nakamura H; Kurachi Y
    J Physiol Sci; 2008 Dec; 58(7):459-70. PubMed ID: 19032804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification models for HERG inhibitors by counter-propagation neural networks.
    Thai KM; Ecker GF
    Chem Biol Drug Des; 2008 Oct; 72(4):279-89. PubMed ID: 18844674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers.
    Aronov AM
    J Med Chem; 2006 Nov; 49(23):6917-21. PubMed ID: 17154521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A binary QSAR model for classification of hERG potassium channel blockers.
    Thai KM; Ecker GF
    Bioorg Med Chem; 2008 Apr; 16(7):4107-19. PubMed ID: 18243713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hERG classification model based on a combination of support vector machine method and GRIND descriptors.
    Li Q; Jørgensen FS; Oprea T; Brunak S; Taboureau O
    Mol Pharm; 2008; 5(1):117-27. PubMed ID: 18197627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D-SDAR modeling of hERG potassium channel affinity: A case study in model design and toxicophore identification.
    Stoyanova-Slavova IB; Slavov SH; Buzatu DA; Beger RD; Wilkes JG
    J Mol Graph Model; 2017 Mar; 72():246-255. PubMed ID: 28129595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channel.
    Schmalhofer WA; Swensen AM; Thomas BS; Felix JP; Haedo RJ; Solly K; Kiss L; Kaczorowski GJ; Garcia ML
    Assay Drug Dev Technol; 2010 Dec; 8(6):714-26. PubMed ID: 21158686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights for human ether-a-go-go-related gene potassium channel inhibition using recursive partitioning and Kohonen and Sammon mapping techniques.
    Ekins S; Balakin KV; Savchuk N; Ivanenkov Y
    J Med Chem; 2006 Aug; 49(17):5059-71. PubMed ID: 16913696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the potency of hERG K⁺ channel inhibition by combining 3D-QSAR pharmacophore and 2D-QSAR models.
    Tan Y; Chen Y; You Q; Sun H; Li M
    J Mol Model; 2012 Mar; 18(3):1023-36. PubMed ID: 21660488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Support vector machines classification of hERG liabilities based on atom types.
    Jia L; Sun H
    Bioorg Med Chem; 2008 Jun; 16(11):6252-60. PubMed ID: 18448342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of the hERG K+ Channel Blockage Using Online Chemical Database and Modeling Environment (OCHEM).
    Li X; Zhang Y; Li H; Zhao Y
    Mol Inform; 2017 Dec; 36(12):. PubMed ID: 28857516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global analysis reveals families of chemical motifs enriched for HERG inhibitors.
    Du F; Babcock JJ; Yu H; Zou B; Li M
    PLoS One; 2015; 10(2):e0118324. PubMed ID: 25700001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of hERG K+ channel blockage using deep neural networks.
    Zhang Y; Zhao J; Wang Y; Fan Y; Zhu L; Yang Y; Chen X; Lu T; Chen Y; Liu H
    Chem Biol Drug Des; 2019 Sep; 94(5):1973-1985. PubMed ID: 31394026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halide ion effects on human Ether-à-go-go related gene potassium channel properties.
    Zeng H; Balasubramanian B; Penniman JR; Kinose F; Salata JJ; Lagrutta A
    Assay Drug Dev Technol; 2013; 11(9-10):544-50. PubMed ID: 24147984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Study on the hERG Blocker Prediction Using Chemical Fingerprint Analysis.
    Choi KE; Balupuri A; Kang NS
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32512802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.